Publications by authors named "Alessandro Strusi"

Claim this Profile
A
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study.
Chiara Ciccarese, Daniela Arduini, Francesca Primi, Ileana Sparagna, Alessandro Strusi

Tumori· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study.
Fabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso, Diana Giannarelli, Jona Barbuta, Alessandro Strusi

Vaccines (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on Belzutifan.
Daniela Arduini, Chiara Ciccarese, Alessandro Strusi, Viria Beccia, Romina Rose Pedone

Curr Cancer Drug Targets· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Roberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, Paolo Andrea Zucali, Emanuela Fantinel, Alessandro Strusi

Eur Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer.
Alessandro Strusi, Giada Pinterpe, Chiara Ciccarese, Romina Rose Pedone, Michele Sarcina

Expert Rev Anticancer Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis.
Chiara Ciccarese, Annunziato Anghelone, Alessio Stefani, Antonio Cigliola, Alessandro Strusi

Expert Rev Anticancer Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives.
Matteo Bauckneht, Chiara Ciccarese, Riccardo Laudicella, Claudia Mosillo, Francesca D'Amico, Alessandro Strusi

Cancer Treat Rev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?
Martina Panebianco, Chiara Ciccarese, Alessandro Strusi, Viria Beccia, Carmine Carbone

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 ASCO genitourinary cancers symposium: focus on renal cell carcinoma.
Annunziato Anghelone, Alessandro Strusi, Alessandro Scala, Martina Panebianco, Chiara Ciccarese

Expert Rev Anticancer Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario.
Chiara Ciccarese, Alessandro Strusi, Daniela Arduini, Pierluigi Russo, Giuseppe Palermo

Cancer Treat Rev· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.
Alessio Stefani, Geny Piro, Francesco Schietroma, Alessandro Strusi, Emanuele Vita

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers.
Roberto Iacovelli, Daniela Arduini, Chiara Ciccarese, Francesco Pierconti, Alessandro Strusi

Crit Rev Oncol Hematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis